Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

被引:446
作者
Postuma, Ronald B. [1 ,2 ]
Aarsland, Dag [3 ]
Barone, Paolo [4 ]
Burn, David J. [5 ]
Hawkes, Christopher H. [6 ]
Oertel, Wolfgang [7 ]
Ziemssen, Tjalf [8 ]
机构
[1] McGill Univ, Montreal Gen Hosp, Dept Neurol, Montreal, PQ H3G 1A4, Canada
[2] Hop Sacre Coeur, Ctr Etud Avancees Med Sommeil, Montreal, PQ H4J 1C5, Canada
[3] Stavanger Univ Hosp, Psychiat Clin, Dept Old Age Psychiat, Stavanger, Norway
[4] Univ Salerno, Ctr Malattie Neurodegenerat, I-84100 Salerno, Italy
[5] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[6] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Neurosci, London, England
[7] Univ Marburg, Dept Neurol, Marburg, Germany
[8] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Neurol Klin & Poliklin, Autonomes & Neuroendokrinol Funkt Lab, Dresden, Germany
关键词
Parkinson's disease; prediction; non-motor; sensitivity; specificity; SLEEP-BEHAVIOR-DISORDER; MILD COGNITIVE IMPAIRMENT; POWER SPECTRAL-ANALYSIS; LEWY BODY DISEASE; OLFACTORY DYSFUNCTION; ODOR IDENTIFICATION; BAROREFLEX SENSITIVITY; DIAGNOSTIC-CRITERIA; COLOR-VISION; TRANSCRANIAL SONOGRAPHY;
D O I
10.1002/mds.24996
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Increasing recognition that Parkinson's disease (PD) may start outside of the substantia nigra has led to a rapidly expanding effort to define prodromal stages of PD, before motor signs permit classical diagnosis. Many of these efforts center around the identification of clinical non-motor symptoms and signs of disease. There is now direct evidence that olfaction, rapid eye movement (REM) sleep behavior disorder (RBD), constipation, and depression can be present in prodromal PD. In addition, there is suggestive evidence that visual changes, other autonomic symptoms, and subtle cognitive changes may also be present at prodromal stages. A critical issue in utility of these prodromal markers will be assessment of sensitivity, specificity, and positive and negative predictive values. Although these have yet to be fully defined, olfactory deficits, some visual changes, and autonomic symptoms occur in the majority of PD patients at diagnosis, suggesting good potential sensitivity. However, with the exception of RBD and perhaps some specific autonomic measures, specificity, and positive predictive value of these markers may be insufficient to be used alone as identifiers of prodromal disease. The evidence for the utility of olfaction, RBD, autonomic markers, visual changes, mood disorders, and cognitive loss as markers of prodromal PD and the potential sensitivity and specificity of these markers are summarized. (C) 2012 Movement Disorder Society
引用
收藏
页码:617 / 626
页数:10
相关论文
共 131 条
[1]   Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography [J].
Aaker, Grant D. ;
Myung, Jane S. ;
Ehrlich, Joshua R. ;
Mohammed, Mujtaba ;
Henchcliffe, Claire ;
Kiss, Szilard .
CLINICAL OPHTHALMOLOGY, 2010, 4 :1427-1432
[2]   Neuropathology of dementia in Parkinson's disease: A prospective, community-based study [J].
Aarsland, D ;
Perry, R ;
Brown, A ;
Larsen, JP ;
Ballard, C .
ANNALS OF NEUROLOGY, 2005, 58 (05) :773-776
[3]   Mild cognitive impairment in Parkinson disease A multicenter pooled analysis [J].
Aarsland, D. ;
Bronnick, K. ;
Williams-Gray, C. ;
Weintraub, D. ;
Marder, K. ;
Kulisevsky, J. ;
Burn, D. ;
Barone, P. ;
Pagonabarraga, J. ;
Allcock, L. ;
Santangelo, G. ;
Foltynie, T. ;
Janvin, C. ;
Larsen, J. P. ;
Barker, R. A. ;
Emre, M. .
NEUROLOGY, 2010, 75 (12) :1062-1069
[4]   Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study [J].
Aarsland, D. ;
Bronnick, K. ;
Larsen, J. P. ;
Tysnes, O. B. ;
Alves, G. .
NEUROLOGY, 2009, 72 (13) :1121-1126
[5]   Frequency of bowel movements and the future risk of Parkinson's disease [J].
Abbott, RD ;
Petrovitch, H ;
White, LR ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Grandinetti, A ;
Blanchette, PL ;
Popper, JS ;
Ross, GW .
NEUROLOGY, 2001, 57 (03) :456-462
[6]   Olfaction in Parkin heterozygotes and compound heterozygotes The CORE-PD study [J].
Alcalay, R. N. ;
Siderowf, A. ;
Ottman, R. ;
Caccappolo, E. ;
Mejia-Santana, H. ;
Tang, M. -X. ;
Rosado, L. ;
Louis, E. ;
Ruiz, D. ;
Waters, C. ;
Fahn, S. ;
Cote, L. ;
Frucht, S. ;
Ford, B. ;
Orbe-Reilly, M. ;
Ross, B. ;
Verbitsky, M. ;
Kisselev, S. ;
Comella, C. ;
Colcher, A. ;
Jennings, D. ;
Nance, M. ;
Bressman, S. ;
Scott, W. K. ;
Tanner, C. ;
Mickel, S. ;
Rezak, M. ;
Novak, K. E. ;
Friedman, J. H. ;
Pfeiffer, R. ;
Marsh, L. ;
Hiner, B. ;
Clark, L. N. ;
Marder, K. .
NEUROLOGY, 2011, 76 (04) :319-326
[7]   Use of antidepressants and the risk of Parkinson's disease: a prospective study [J].
Alonso, A. ;
Garcia Rodriguez, L. A. ;
Logroscino, G. ;
Hernan, M. A. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (06) :671-674
[8]   Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease [J].
Altintas, Ozgul ;
Iseri, Pervin ;
Orzkan, Berna ;
Caglar, Yusuf .
DOCUMENTA OPHTHALMOLOGICA, 2008, 116 (02) :137-146
[9]  
[Anonymous], 2005, INT CLASSIFICATION S
[10]   Retinal thickness in Parkinson's disease [J].
Archibald, N. K. ;
Clarke, M. P. ;
Mosimann, U. P. ;
Burn, D. J. .
PARKINSONISM & RELATED DISORDERS, 2011, 17 (06) :431-436